Cargando…
Reducing ventilator-associated pneumonia in neonatal intensive care unit using “VAP prevention Bundle”: a cohort study
BACKGROUND: Ventilator-associated pneumonia (VAP) is a serious health care- associated infection, resulting in high morbidity and mortality. It also prolongs hospital stay and drives up hospital costs. Measures employed in preventing ventilator- associated pneumonia in developing countries are rarel...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527219/ https://www.ncbi.nlm.nih.gov/pubmed/26246314 http://dx.doi.org/10.1186/s12879-015-1062-1 |
_version_ | 1782384536101847040 |
---|---|
author | Azab, Seham F. A. Sherbiny, Hanan S. Saleh, Safaa H. Elsaeed, Wafaa F. Elshafiey, Mona M. Siam, Ahmed G. Arafa, Mohamed A. Alghobashy, Ashgan A. Bendary, Eman A. Basset, Maha A. A. Ismail, Sanaa M. Akeel, Nagwa E. Elsamad, Nahla A. mokhtar, Wesam A. Gheith, Tarek |
author_facet | Azab, Seham F. A. Sherbiny, Hanan S. Saleh, Safaa H. Elsaeed, Wafaa F. Elshafiey, Mona M. Siam, Ahmed G. Arafa, Mohamed A. Alghobashy, Ashgan A. Bendary, Eman A. Basset, Maha A. A. Ismail, Sanaa M. Akeel, Nagwa E. Elsamad, Nahla A. mokhtar, Wesam A. Gheith, Tarek |
author_sort | Azab, Seham F. A. |
collection | PubMed |
description | BACKGROUND: Ventilator-associated pneumonia (VAP) is a serious health care- associated infection, resulting in high morbidity and mortality. It also prolongs hospital stay and drives up hospital costs. Measures employed in preventing ventilator- associated pneumonia in developing countries are rarely reported. In this study we tried to assess the efficacy of our designed “VAP prevention bundle” in reducing VAP rate in our neonatal intensive care unit (NICU). METHOD: This prospective before-and-after study was conducted at university hospital NICU, all neonates who had mechanical ventilation for ≥ 48 h were eligible. VAP rates were evaluated before (phase-I) and after (phase-II) full implementation of comprehensive preventive measures specifically designed by our infection control team. RESULTS: Of 143 mechanically ventilated neonates, 73 patients developed VAP (51 %) throughout the study period (2500 mechanical ventilation days). The rate of VAP was significantly reduced from 67.8 % (42/62) corresponding to 36.4 VAP episodes/1000 mechanical ventilation days (MV days) in phase-I to 38.2 % (31/81) corresponding to 23 VAP/1000 MV days (RR 0.565, 95 % confidence interval 0.408-0.782, p = 0.0006) after VAP prevention bundle implementation (phase-II). Parallel significant reduction in MV days/case were documented in post-intervention period (21.50 ± 7.6 days in phase-I versus 10.36 ± 5.2 days in phase-II, p = 0.000). There were a trend toward reduction in NICU length of stay (23.9 ± 10.3 versus 22.8 ± 9.6 days, p = 0.56) and overall mortality (25 % versus 17.3 %, p = 0.215) between the two phases but didn’t reach statistical significance. The commonest micro-organisms isolated throughout the study were gram-negative bacteria (63/66, 95.5 %) particularly Klebsilla pneumonia (55/66, 83.4 %). CONCLUSION: Implementation of multifaceted infection control bundle resulted in reduction of VAP rate, length of stay in our NICU. |
format | Online Article Text |
id | pubmed-4527219 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45272192015-08-07 Reducing ventilator-associated pneumonia in neonatal intensive care unit using “VAP prevention Bundle”: a cohort study Azab, Seham F. A. Sherbiny, Hanan S. Saleh, Safaa H. Elsaeed, Wafaa F. Elshafiey, Mona M. Siam, Ahmed G. Arafa, Mohamed A. Alghobashy, Ashgan A. Bendary, Eman A. Basset, Maha A. A. Ismail, Sanaa M. Akeel, Nagwa E. Elsamad, Nahla A. mokhtar, Wesam A. Gheith, Tarek BMC Infect Dis Research Article BACKGROUND: Ventilator-associated pneumonia (VAP) is a serious health care- associated infection, resulting in high morbidity and mortality. It also prolongs hospital stay and drives up hospital costs. Measures employed in preventing ventilator- associated pneumonia in developing countries are rarely reported. In this study we tried to assess the efficacy of our designed “VAP prevention bundle” in reducing VAP rate in our neonatal intensive care unit (NICU). METHOD: This prospective before-and-after study was conducted at university hospital NICU, all neonates who had mechanical ventilation for ≥ 48 h were eligible. VAP rates were evaluated before (phase-I) and after (phase-II) full implementation of comprehensive preventive measures specifically designed by our infection control team. RESULTS: Of 143 mechanically ventilated neonates, 73 patients developed VAP (51 %) throughout the study period (2500 mechanical ventilation days). The rate of VAP was significantly reduced from 67.8 % (42/62) corresponding to 36.4 VAP episodes/1000 mechanical ventilation days (MV days) in phase-I to 38.2 % (31/81) corresponding to 23 VAP/1000 MV days (RR 0.565, 95 % confidence interval 0.408-0.782, p = 0.0006) after VAP prevention bundle implementation (phase-II). Parallel significant reduction in MV days/case were documented in post-intervention period (21.50 ± 7.6 days in phase-I versus 10.36 ± 5.2 days in phase-II, p = 0.000). There were a trend toward reduction in NICU length of stay (23.9 ± 10.3 versus 22.8 ± 9.6 days, p = 0.56) and overall mortality (25 % versus 17.3 %, p = 0.215) between the two phases but didn’t reach statistical significance. The commonest micro-organisms isolated throughout the study were gram-negative bacteria (63/66, 95.5 %) particularly Klebsilla pneumonia (55/66, 83.4 %). CONCLUSION: Implementation of multifaceted infection control bundle resulted in reduction of VAP rate, length of stay in our NICU. BioMed Central 2015-08-06 /pmc/articles/PMC4527219/ /pubmed/26246314 http://dx.doi.org/10.1186/s12879-015-1062-1 Text en © Azab et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Azab, Seham F. A. Sherbiny, Hanan S. Saleh, Safaa H. Elsaeed, Wafaa F. Elshafiey, Mona M. Siam, Ahmed G. Arafa, Mohamed A. Alghobashy, Ashgan A. Bendary, Eman A. Basset, Maha A. A. Ismail, Sanaa M. Akeel, Nagwa E. Elsamad, Nahla A. mokhtar, Wesam A. Gheith, Tarek Reducing ventilator-associated pneumonia in neonatal intensive care unit using “VAP prevention Bundle”: a cohort study |
title | Reducing ventilator-associated pneumonia in neonatal intensive care unit using “VAP prevention Bundle”: a cohort study |
title_full | Reducing ventilator-associated pneumonia in neonatal intensive care unit using “VAP prevention Bundle”: a cohort study |
title_fullStr | Reducing ventilator-associated pneumonia in neonatal intensive care unit using “VAP prevention Bundle”: a cohort study |
title_full_unstemmed | Reducing ventilator-associated pneumonia in neonatal intensive care unit using “VAP prevention Bundle”: a cohort study |
title_short | Reducing ventilator-associated pneumonia in neonatal intensive care unit using “VAP prevention Bundle”: a cohort study |
title_sort | reducing ventilator-associated pneumonia in neonatal intensive care unit using “vap prevention bundle”: a cohort study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527219/ https://www.ncbi.nlm.nih.gov/pubmed/26246314 http://dx.doi.org/10.1186/s12879-015-1062-1 |
work_keys_str_mv | AT azabsehamfa reducingventilatorassociatedpneumoniainneonatalintensivecareunitusingvappreventionbundleacohortstudy AT sherbinyhanans reducingventilatorassociatedpneumoniainneonatalintensivecareunitusingvappreventionbundleacohortstudy AT salehsafaah reducingventilatorassociatedpneumoniainneonatalintensivecareunitusingvappreventionbundleacohortstudy AT elsaeedwafaaf reducingventilatorassociatedpneumoniainneonatalintensivecareunitusingvappreventionbundleacohortstudy AT elshafieymonam reducingventilatorassociatedpneumoniainneonatalintensivecareunitusingvappreventionbundleacohortstudy AT siamahmedg reducingventilatorassociatedpneumoniainneonatalintensivecareunitusingvappreventionbundleacohortstudy AT arafamohameda reducingventilatorassociatedpneumoniainneonatalintensivecareunitusingvappreventionbundleacohortstudy AT alghobashyashgana reducingventilatorassociatedpneumoniainneonatalintensivecareunitusingvappreventionbundleacohortstudy AT bendaryemana reducingventilatorassociatedpneumoniainneonatalintensivecareunitusingvappreventionbundleacohortstudy AT bassetmahaaa reducingventilatorassociatedpneumoniainneonatalintensivecareunitusingvappreventionbundleacohortstudy AT ismailsanaam reducingventilatorassociatedpneumoniainneonatalintensivecareunitusingvappreventionbundleacohortstudy AT akeelnagwae reducingventilatorassociatedpneumoniainneonatalintensivecareunitusingvappreventionbundleacohortstudy AT elsamadnahlaa reducingventilatorassociatedpneumoniainneonatalintensivecareunitusingvappreventionbundleacohortstudy AT mokhtarwesama reducingventilatorassociatedpneumoniainneonatalintensivecareunitusingvappreventionbundleacohortstudy AT gheithtarek reducingventilatorassociatedpneumoniainneonatalintensivecareunitusingvappreventionbundleacohortstudy |